Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Eurofins FY Revenue At EUR 6.76 Bln, Confirms 2027 Outlook

Jan 29 (Reuters) - Eurofins Scientific SE EUFI.PA:

DELIVERS FY 2025 OBJECTIVES WITH A 24% EPS GROWTH, ACCELERATING ORGANIC REVENUE GROWTH, MARGIN EXPANSION, AND HIGHER FREE CASH FLOW AND CONFIRMS ITS 2027 OBJECTIVES

BASIC EPS8 GREW 24% TO EUR 2.31 IN 2025 VERSUS EUR 1.87 IN 2024

FY REVENUE AT EUR 6,756 MILLION

FY EBITDA EUR 1,641 MILLION

NET DEBT AT THE END OF DEC 2025 EUR 3,641 MILLION

FY FCF TO FIRM BEFORE INVESTMENT IN OWNED SITES AT EUR 1,071 MILLION

FOR FY 2026 TARGETS MID-SINGLE-DIGIT ORGANIC GROWTH AND POTENTIAL ANNUALISED REVENUES FROM ACQUISITIONS OF EUR 250 MILLION, CONSOLIDATED AT MID-YEAR

FOR FY 2026 ADJUSTED EBITDA MARGIN EXPECTED TO SHOW FURTHER PROGRESS TOWARDS 2027 OBJECTIVE, WITH IMPROVEMENT ABOVE FY 2025 MARGIN

CONFIRMS ITS OBJECTIVES FOR MID-TERM (POST-2027) AND FOR FY 2027

Source text: ID: nBwVcP05a

Further company coverage: EUFI.PA

(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00; ))

Recent news on Eurofins Scientific SE

See all news